Topotecan: Incorporating It Into the Treatment of Solid Tumors-Reference-Cited by-同舟云学术

Topotecan: Incorporating It Into the Treatment of Solid Tumors

Published:1998-02 Issue:1 Volume:3 Page:1-3
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:The Oncologist

Author:

Burris Howard A.¹

Affiliation:

1. Sarah Cannon Cancer Center, Nashville, Tennessee, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.3-1-1

Reference16 articles.

1. Clinical Guidelines for Managing Topotecan‐Related Hematologic Toxicity

2. The Role of Topotecan in the Treatment of Small Cell Lung Cancer

3. Efficacy of topotecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel: international topotecan study group trial;Gordon A;Proc Am Soc Clin Oncol,1996

4. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

5. Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Convection-enhanced drug delivery for glioblastoma: a review;Journal of Neuro-Oncology;2021-02

2. Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model;Journal of Neurosurgery;2020-09

3. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches;Anti-Cancer Agents in Medicinal Chemistry;2020-07-08

4. A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer;Investigational New Drugs;2017-12-26

5. Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability;Biomaterials Science;2017